Home AstraZeneca plc (AZN) Earns "Outperform" Rating from BNP Paribas
 

Keywords :   


AstraZeneca plc (AZN) Earns "Outperform" Rating from BNP Paribas

2015-11-30 21:21:56| Biotech - Topix.net

's stock had its "outperform" rating reaffirmed by research analysts at BNP Paribas in a research note issued to investors on Monday, AnalystRatings.NET reports. AstraZeneca plc traded up 0.09% during trading on Monday, reaching $34.08.

Tags: rating plc earns bnp

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
03.07Hurricane Beryl Graphics
03.07Atlantic Tropical Weather Outlook
03.07Hurricane Beryl Public Advisory Number 17A
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Eastern North Pacific Tropical Weather Outlook
03.07How Microsoft and Nvidia bet correctly to leapfrog Apple
03.07Lakamps research aims to use cattle genetics and microbiome information to make performance predictions
03.07Keep livestock safe during hurricane season with an emergency plan
More »